These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8287001)

  • 21. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.
    Lima ES; Friedman SR; Bastos FI; Telles PR; Friedmann P; Ward TP; des Jarlais DC
    Addiction; 1994 Jun; 89(6):689-98. PubMed ID: 8069170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Young injectors: a comparative analysis of risk behaviour.
    Cassin S; Geoghegan T; Cox G
    Ir J Med Sci; 1998; 167(4):234-7. PubMed ID: 9868862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Awareness of sexual partners' HIV status as an influence upon high-risk sexual behaviour among gay men.
    Dawson JM; Fitzpatrick RM; Reeves G; Boulton M; McLean J; Hart GJ; Brookes M
    AIDS; 1994 Jun; 8(6):837-41. PubMed ID: 8086144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran.
    Mehrjerdi ZA; Abarashi Z; Noroozi A; Arshad L; Zarghami M
    Int J STD AIDS; 2014 May; 25(6):420-7. PubMed ID: 24287028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Friendships are a big part of it": social relationships, social distance, and HIV risks.
    Hughes R
    Subst Use Misuse; 2000 Aug; 35(9):1149-76. PubMed ID: 11349680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia.
    Tavitian-Exley I; Maheu-Giroux M; Platt L; Heimer R; Uusküla A; Levina O; Vickerman P; Boily MC
    Int J Drug Policy; 2018 Mar; 53():96-105. PubMed ID: 29306786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of HIV, hepatitis B and associated risk behaviours in clients of a needle-exchange in central London.
    Hart GJ; Woodward N; Johnson AM; Tighe J; Parry JV; Adler MW
    AIDS; 1991 May; 5(5):543-7. PubMed ID: 1863406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injecting drug use, sexual risk, HIV knowledge and harm reduction uptake in a large prison in Bali, Indonesia.
    Sawitri AA; Hartawan AA; Craine N; Sari AK; Septarini NW; Wirawan DN
    Int J Prison Health; 2016; 12(1):27-38. PubMed ID: 26933990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users.
    Desenclos JC; Papaevangelou G; Ancelle-Park R
    AIDS; 1993 Oct; 7(10):1371-7. PubMed ID: 8267911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis on factors associated with taking subsequent confirmation test among men who have sex with men after being tested positive in oral fluid HIV antibody test in Beijing].
    Xia D; Liu G; Zeng J; Li Y; Su X; Sun W; Li J; Zhang Q; Hao M; Ye J; Xin R; Zhao Y; Wang J; Lu H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Feb; 50(2):153-7. PubMed ID: 26926724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adolescents, sex and injecting drug use: risks for HIV infection.
    Barnard M; McKeganey N
    AIDS Care; 1990; 2(2):103-16. PubMed ID: 2085532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV status knowledge and risk behaviours amongst intravenous drug users.
    Vidal-Trécan G; Coste J; Varescon-Pousson I; Christoforov B; Boissonnas A
    Eur J Epidemiol; 2000 May; 16(5):439-45. PubMed ID: 10997831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV prevalence and risk factors in university students.
    Raab GM; Burns SM; Scott G; Cudmore S; Ross A; Gore SM; O'Brien F; Shaw T
    AIDS; 1995 Feb; 9(2):191-7. PubMed ID: 7718191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV risk behaviour in Irish intravenous drug users.
    Dorman A; Keenan E; Schuttler C; Merry J; O'Connor JJ
    Ir J Med Sci; 1997; 166(4):235-8. PubMed ID: 9394073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.
    Salmon AM; van Beek I; Amin J; Grulich A; Maher L
    Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexual behaviour in injecting drug users.
    Ross MW; Wodak A; Gold J
    J Psychol Human Sex; 1992; 5(1-2):89-104. PubMed ID: 12288843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulant injectors in Ukraine: the next wave of the epidemic?
    Booth RE; Lehman WE; Kwiatkowski CF; Brewster JT; Sinitsyna L; Dvoryak S
    AIDS Behav; 2008 Jul; 12(4):652-61. PubMed ID: 18264752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a longitudinal community HIV intervention targeting injecting drug users' stage of change for condom and bleach use.
    Jamner MS; Wolitski RJ; Corby NH
    Am J Health Promot; 1997; 12(1):15-24. PubMed ID: 10170430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.